Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

Market: Pharmaceuticals and Healthcare

Global, 162 pages report, published by GlobalData

Report ThumbnailSeptember-2018
Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

Summary

Market access of oncology medicines is increasingly challenging due to the rising cost of new and innovative medicines, more stringent scientific and value assessments and economic pressures on national budgets and health systems. Although, 5EU markets have implemented patient access schemed to ensure early access to innovative oncology medicines with high unmet need, the increasing requirements for improved clin

Read More
  • Table of Contents
  • 1. Preface 2
  • 1.1 Table of Contents 3
  • 1.2 Abbreviations 5
  • 1.3 Related Reports 11
  • 1.4 Upcoming Related Reports 12
  • 2. Executive Summary 13
  • 2.1 Key Findings 14
  • 2.2 KOL and Payer Insights on Market Access, Pricing and Reimbursement in Oncology in the 5EU 15
  • 3. Overview of Market Access, Pricing and Reimbursement 16
  • 3.1 Cancer in Europe 18
  • 3.2 What is Market Access? 19
  • 3.3 Marketing Authorization 20
  • 3.4 Marketing Authorization for Early Patient Access 21
  • 3.5 Cancer Medicines Approved
Read More

Please select a license type

Share

Related Products

GlobalDataMarket Access, Pricing and Reimbursement of Oncology Medicines in the 5EUProduct ThumbnailMarket Access, Pricing and Reimbursement of Oncology Medicines in the 5EU, Industry ReportProduct #: 1190977
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2019 Global Market Analyst. All Rights Reserved